Theseus Pharmaceuticals Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2019	FY 2018	FY 2017
Period Ending	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Equivalents	3,132	4,549	8.15
Cash & Short-Term Investments	3,132	4,549	8.15
Cash Growth	-31.15%	55693.52%	-
Accounts Receivable	0.22	0.22	-
Other Receivables	9.18	59.12	4.55
Receivables	9.4	59.34	95.09
Prepaid Expenses	0.54	7.72	0.89
Other Current Assets	79.64	49.81	0.34
Total Current Assets	3,221	4,666	104.47
Property, Plant & Equipment	312.66	470.69	157.89
Other Intangible Assets	22.49	25.66	53.13
Other Long-Term Assets	168.21	236.57	98.78
Total Assets	3,725	5,399	414.26
Accrued Expenses	12.79	11.27	4.62
Short-Term Debt	-	-	310
Current Portion of Long-Term Debt	284.65	267.13	-
Other Current Liabilities	30.48	25.77	25.9
Total Current Liabilities	327.93	304.17	340.52
Other Long-Term Liabilities	-0	-	-
Total Liabilities	438.17	366.13	367.18
Common Stock	3,134	1,041	900
Additional Paid-In Capital	3,570	6,101	-
Retained Earnings	-4,527	-2,327	-852.92
Comprehensive Income & Other	467.93	-	-
Total Common Equity	2,646	4,815	47.08
Shareholders' Equity	3,287	5,033	47.08
Total Liabilities & Equity	3,725	5,399	414.26
Total Debt	284.65	267.13	310
Net Cash (Debt)	2,847	4,282	-301.85
Net Cash Growth	-33.51%	-	-
Net Cash Per Share	453.59	2056.76	-167.72
Filing Date Shares Outstanding	6.28	2.08	1.8
Total Common Shares Outstanding	6.28	2.08	1.8
Working Capital	2,893	4,362	-236.05
Book Value Per Share	421.49	2312.99	26.16
Tangible Book Value	2,623	4,789	-6.05
Tangible Book Value Per Share	417.90	2300.66	-3.36
Machinery	598.19	547.42	201.46
Construction In Progress	-	-	13.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.